Unlock stock picks and a broker-level newsfeed that powers Wall Street.

US High Growth Tech Stocks to Watch

In This Article:

Amidst a backdrop of heightened market volatility driven by tariff uncertainties, the U.S. tech sector has experienced significant fluctuations, with major indices like the Nasdaq Composite seeing dramatic shifts in response to recent economic policies. In such an environment, high growth tech stocks that demonstrate resilience through innovation and adaptability become particularly noteworthy for investors seeking opportunities amidst broader market turbulence.

Top 10 High Growth Tech Companies In The United States

Name

Revenue Growth

Earnings Growth

Growth Rating

Super Micro Computer

20.44%

29.79%

★★★★★★

TG Therapeutics

26.03%

37.60%

★★★★★★

Alkami Technology

20.46%

85.16%

★★★★★★

Travere Therapeutics

28.56%

65.75%

★★★★★★

Arcutis Biotherapeutics

25.76%

58.17%

★★★★★★

Alnylam Pharmaceuticals

22.73%

58.77%

★★★★★★

TKO Group Holdings

22.48%

25.17%

★★★★★★

AVITA Medical

28.21%

56.12%

★★★★★★

Lumentum Holdings

21.61%

120.49%

★★★★★★

Ascendis Pharma

32.36%

59.79%

★★★★★★

Click here to see the full list of 231 stocks from our US High Growth Tech and AI Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Advanced Energy Industries

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Advanced Energy Industries, Inc. specializes in delivering precision power conversion, measurement, and control solutions globally with a market capitalization of approximately $3.61 billion.

Operations: AEIS generates revenue primarily from its Power Electronics Conversion Products segment, which reported $1.48 billion in sales. The company's focus is on providing advanced power solutions across various industries worldwide.

Advanced Energy Industries (AEIS) demonstrates a nuanced growth trajectory with its earnings forecast to surge by 53.7% annually, outpacing the broader US market's 13.6%. This robust earnings growth contrasts starkly with its more modest revenue increase of 8.4% per year, which still slightly exceeds the national average of 8.3%. Strategically, AEIS is leveraging its strong balance sheet for potential acquisitions that could enhance its technological breadth and market position in sectors like industrial medical. Recent financials reveal a mixed picture: while Q4 sales rose to $415.4 million from $405.27 million year-over-year, annual sales dipped to $1,482 million from $1,655 million previously. Despite this fluctuation in revenue streams, AEIS's proactive management strategies and investment in R&D could position it favorably within the high-tech landscape as it navigates through these evolving market dynamics.